Thus, the clinically therapeutic strategy for T2DM should not only effectively control the patients glucose levels, but also minimize the complications of bone metabolism diseases
For patients paying fully out of pocket, savings of up to 65% could reduce annual treatment costs by thousands of dollars compared with current brand-name pricing
The trial demonstrated that approximately 35% of semaglutide-induced weight loss was due to loss of lean mass and further demonstrated that combining semaglutide with trevogrumab with or without garetosmab helped preserve lean mass while increasing loss of fat mass
To address this, the American Journal of Clinical Nutrition released dietary guidelines for GLP-1 users in July 2025
Large outcomes trials have not shown a significantly higher pancreatitis incidence with GLP-1 RAs versus placebo, but the labeling still lists it as a warning
With repeat episodes or severe obstipation, investigations for an underlying cause should be thorough and include evaluation for colonic mass obstructions
